Zohair Al-Halees, Mosleh Nazzal Alanazi, Patricia Machado, Mary Jane Maghirang, Emad Hakami, Farouk Mostafa Faris, Michelle Gretchen Lo, Mohamed Laimoud
{"title":"静脉体外膜氧合过程中的脑血管中风。","authors":"Zohair Al-Halees, Mosleh Nazzal Alanazi, Patricia Machado, Mary Jane Maghirang, Emad Hakami, Farouk Mostafa Faris, Michelle Gretchen Lo, Mohamed Laimoud","doi":"10.1155/ccrp/9058296","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving mechanical support in patients with cardiogenic shock. There are great variations in the reported rates of neurological complications and associated mortality. Our aim was to analyze our cohort of adult patients supported with VA-ECMO to identify the incidence, outcomes, and predictors of acute ischemic and hemorrhagic strokes.</p><p><strong>Methods: </strong>A total of 195 patients between January 2016 and January 2023 were reviewed, 22 (11.3%) ECPR patients were excluded, and 173 (88.7%) patients were analyzed. We divided the patients into stroke and nonstroke groups according to the presence of radiologically confirmed acute ischemic and hemorrhagic strokes.</p><p><strong>Results: </strong>Thirty-five (20.2%) patients had acute cerebrovascular strokes. 13 (7.5%) patients had intracranial hemorrhage (ICH) while 22 (12.7%) patients had ischemic stroke. The median age was 48 years (IQR: 31, 56), 98 (56.6%) patients were males, and 152 (87.9%) patients had cardiac surgeries. The patients who developed cerebrovascular stroke had higher blood lactate at ECMO initiation (8.9 [5.5, 11.2] versus 5.7 [4.6, 11.9] mmol/L, <i>p</i> = 0.02) and 12 h later (8.7 [4.7, 14.5] versus 5.8 [4.6, 15] mmol/L, <i>p</i> = 0.024) with lesser lactate clearance (LC) at 12 h (6.35 [-51.5, 40.6] versus 14.65% [-43.55, 38.3], <i>p</i> < 001) compared to the patients in the nonstroke group. The stroke group had longer ICU stay (21 vs. 15.5 days, <i>p</i> = 0.03), higher frequency of new hemodialysis (62.9% vs. 46.4%, <i>p</i> = 0.026), and on-ECMO mortality (54.3% vs. 44.9%, <i>p</i> = 0.041) compared with the nonstroke group. The ICH was associated with higher hospital mortality (<i>p</i> = 0.021) compared to the ischemic stroke. Logistic multivariate regression revealed that the initial lactate level (OR: 1.6, 95% CI: 1.2-8.92, <i>p</i> = 0.031), cardiopulmonary bypass time (OR:1.8, 95% CI: 1.32-6.42, <i>p</i> = 0.02), and LC at 12 h (OR: 2.4, 95% CI: 1.91-17.4, <i>p</i> = 0.042) were associated with ischemic stroke. Thrombocytopenia (OR: 3.22, 95% CI: 1.82-7.83, <i>p</i> = 0.001) and low body mass index (OR: 2.1, 95% CI: 1.31-4.6, <i>p</i> = 0.02) were associated with ICH.</p><p><strong>Conclusions: </strong>Ischemic and hemorrhagic strokes are frequent with VA-ECMO support and associated with worse outcomes, especially the hemorrhagic type. Awareness of the incidence and the factors associated with strokes is crucial in early identification and management.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2025 ","pages":"9058296"},"PeriodicalIF":1.8000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12540010/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cerebrovascular Strokes During Venoarterial Extracorporeal Membrane Oxygenation.\",\"authors\":\"Zohair Al-Halees, Mosleh Nazzal Alanazi, Patricia Machado, Mary Jane Maghirang, Emad Hakami, Farouk Mostafa Faris, Michelle Gretchen Lo, Mohamed Laimoud\",\"doi\":\"10.1155/ccrp/9058296\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving mechanical support in patients with cardiogenic shock. There are great variations in the reported rates of neurological complications and associated mortality. Our aim was to analyze our cohort of adult patients supported with VA-ECMO to identify the incidence, outcomes, and predictors of acute ischemic and hemorrhagic strokes.</p><p><strong>Methods: </strong>A total of 195 patients between January 2016 and January 2023 were reviewed, 22 (11.3%) ECPR patients were excluded, and 173 (88.7%) patients were analyzed. We divided the patients into stroke and nonstroke groups according to the presence of radiologically confirmed acute ischemic and hemorrhagic strokes.</p><p><strong>Results: </strong>Thirty-five (20.2%) patients had acute cerebrovascular strokes. 13 (7.5%) patients had intracranial hemorrhage (ICH) while 22 (12.7%) patients had ischemic stroke. The median age was 48 years (IQR: 31, 56), 98 (56.6%) patients were males, and 152 (87.9%) patients had cardiac surgeries. The patients who developed cerebrovascular stroke had higher blood lactate at ECMO initiation (8.9 [5.5, 11.2] versus 5.7 [4.6, 11.9] mmol/L, <i>p</i> = 0.02) and 12 h later (8.7 [4.7, 14.5] versus 5.8 [4.6, 15] mmol/L, <i>p</i> = 0.024) with lesser lactate clearance (LC) at 12 h (6.35 [-51.5, 40.6] versus 14.65% [-43.55, 38.3], <i>p</i> < 001) compared to the patients in the nonstroke group. The stroke group had longer ICU stay (21 vs. 15.5 days, <i>p</i> = 0.03), higher frequency of new hemodialysis (62.9% vs. 46.4%, <i>p</i> = 0.026), and on-ECMO mortality (54.3% vs. 44.9%, <i>p</i> = 0.041) compared with the nonstroke group. The ICH was associated with higher hospital mortality (<i>p</i> = 0.021) compared to the ischemic stroke. Logistic multivariate regression revealed that the initial lactate level (OR: 1.6, 95% CI: 1.2-8.92, <i>p</i> = 0.031), cardiopulmonary bypass time (OR:1.8, 95% CI: 1.32-6.42, <i>p</i> = 0.02), and LC at 12 h (OR: 2.4, 95% CI: 1.91-17.4, <i>p</i> = 0.042) were associated with ischemic stroke. Thrombocytopenia (OR: 3.22, 95% CI: 1.82-7.83, <i>p</i> = 0.001) and low body mass index (OR: 2.1, 95% CI: 1.31-4.6, <i>p</i> = 0.02) were associated with ICH.</p><p><strong>Conclusions: </strong>Ischemic and hemorrhagic strokes are frequent with VA-ECMO support and associated with worse outcomes, especially the hemorrhagic type. Awareness of the incidence and the factors associated with strokes is crucial in early identification and management.</p>\",\"PeriodicalId\":46583,\"journal\":{\"name\":\"Critical Care Research and Practice\",\"volume\":\"2025 \",\"pages\":\"9058296\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12540010/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care Research and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/ccrp/9058296\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/ccrp/9058296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
背景:静脉体外膜氧合(VA-ECMO)是一种挽救心源性休克患者生命的机械支持。在报道的神经系统并发症和相关死亡率方面存在很大差异。我们的目的是分析支持VA-ECMO的成年患者队列,以确定急性缺血性和出血性卒中的发生率、结局和预测因素。方法:回顾性分析2016年1月至2023年1月共195例患者,排除22例(11.3%)ECPR患者,分析173例(88.7%)患者。根据影像学证实的急性缺血性和出血性脑卒中,我们将患者分为脑卒中组和非脑卒中组。结果:急性脑血管卒中35例(20.2%)。颅内出血13例(7.5%),缺血性脑卒中22例(12.7%)。中位年龄48岁(IQR: 31,56),男性98例(56.6%),心脏手术152例(87.9%)。发生脑血管卒中的患者在ECMO开始时(8.9[5.5,11.2]比5.7 [4.6,11.9]mmol/L, p = 0.02)和12小时后(8.7[4.7,14.5]比5.8 [4.6,15]mmol/L, p = 0.024)血乳酸清除率(LC)较低(6.35[-51.5,40.6]比14.65% [-43.55,38.3],p < 001)与非卒中组相比。与非卒中组相比,卒中组ICU住院时间更长(21天对15.5天,p = 0.03),新血液透析频率更高(62.9%对46.4%,p = 0.026), ecmo死亡率更高(54.3%对44.9%,p = 0.041)。与缺血性脑卒中相比,脑出血与更高的住院死亡率相关(p = 0.021)。Logistic多因素回归显示,初始乳酸水平(OR: 1.6, 95% CI: 1.2 ~ 8.92, p = 0.031)、体外循环时间(OR:1.8, 95% CI: 1.32 ~ 6.42, p = 0.02)和12 h LC (OR: 2.4, 95% CI: 1.91 ~ 17.4, p = 0.042)与缺血性卒中相关。血小板减少症(OR: 3.22, 95% CI: 1.82-7.83, p = 0.001)和低体重指数(OR: 2.1, 95% CI: 1.31-4.6, p = 0.02)与脑出血相关。结论:在VA-ECMO支持下,缺血性和出血性卒中发生率较高,且预后较差,尤其是出血性卒中。了解与中风相关的发病率和因素对早期识别和治疗至关重要。
Cerebrovascular Strokes During Venoarterial Extracorporeal Membrane Oxygenation.
Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving mechanical support in patients with cardiogenic shock. There are great variations in the reported rates of neurological complications and associated mortality. Our aim was to analyze our cohort of adult patients supported with VA-ECMO to identify the incidence, outcomes, and predictors of acute ischemic and hemorrhagic strokes.
Methods: A total of 195 patients between January 2016 and January 2023 were reviewed, 22 (11.3%) ECPR patients were excluded, and 173 (88.7%) patients were analyzed. We divided the patients into stroke and nonstroke groups according to the presence of radiologically confirmed acute ischemic and hemorrhagic strokes.
Results: Thirty-five (20.2%) patients had acute cerebrovascular strokes. 13 (7.5%) patients had intracranial hemorrhage (ICH) while 22 (12.7%) patients had ischemic stroke. The median age was 48 years (IQR: 31, 56), 98 (56.6%) patients were males, and 152 (87.9%) patients had cardiac surgeries. The patients who developed cerebrovascular stroke had higher blood lactate at ECMO initiation (8.9 [5.5, 11.2] versus 5.7 [4.6, 11.9] mmol/L, p = 0.02) and 12 h later (8.7 [4.7, 14.5] versus 5.8 [4.6, 15] mmol/L, p = 0.024) with lesser lactate clearance (LC) at 12 h (6.35 [-51.5, 40.6] versus 14.65% [-43.55, 38.3], p < 001) compared to the patients in the nonstroke group. The stroke group had longer ICU stay (21 vs. 15.5 days, p = 0.03), higher frequency of new hemodialysis (62.9% vs. 46.4%, p = 0.026), and on-ECMO mortality (54.3% vs. 44.9%, p = 0.041) compared with the nonstroke group. The ICH was associated with higher hospital mortality (p = 0.021) compared to the ischemic stroke. Logistic multivariate regression revealed that the initial lactate level (OR: 1.6, 95% CI: 1.2-8.92, p = 0.031), cardiopulmonary bypass time (OR:1.8, 95% CI: 1.32-6.42, p = 0.02), and LC at 12 h (OR: 2.4, 95% CI: 1.91-17.4, p = 0.042) were associated with ischemic stroke. Thrombocytopenia (OR: 3.22, 95% CI: 1.82-7.83, p = 0.001) and low body mass index (OR: 2.1, 95% CI: 1.31-4.6, p = 0.02) were associated with ICH.
Conclusions: Ischemic and hemorrhagic strokes are frequent with VA-ECMO support and associated with worse outcomes, especially the hemorrhagic type. Awareness of the incidence and the factors associated with strokes is crucial in early identification and management.